(Q37511034)

20 August 2017

1 reference

title

Recent cancer drug development with xanthone structures (English)

1 reference

20 August 2017

Younghwa Na

1

1 reference

20 August 2017

1 June 2009

1 reference

Journal of Pharmacy and Pharmacology

20 August 2017

1 reference

20 August 2017

61

1 reference

20 August 2017

6

1 reference

20 August 2017

707-712

1 reference

Synthesis of xanthones: an overview

20 August 2017

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Naturally-occurring xanthones: recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Xanthones--a structural perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Xanthones as antimalarial agents: discovery, mode of action, and optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Tetraoxygenated naturally occurring xanthones

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Xanthone derivatives: new insights in biological activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Potential cancer chemopreventive in vitro activities of monomeric xanthone derivatives from the marine algicolous fungus Monodictys putredinis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Preferential target is mitochondria in alpha-mangostin-induced apoptosis in human leukemia HL60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Psorospermin, a new antileukemic xanthone from Psorospermum febrifugum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Topoisomerase II site-directed alkylation of DNA by psorospermin and its effect on topoisomerase II-mediated DNA cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Phomoxanthones A and B, novel xanthone dimers from the endophytic fungus Phomopsis species

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Cytotoxic caged-polyprenylated xanthonoids and a xanthone from Garcinia cantleyana

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Synthesis of caged 2,3,3a,7a-tetrahydro-3,6-methanobenzofuran-7(6H)-ones: Evaluating the minimum structure for apoptosis induction by gambogic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

A new dihydroxanthenone from a plant-associated strain of the fungus Chaetomium globosum demonstrates anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Synthesis, and cytotoxic and antiplatelet activities of oxime- and methyloxime-containing flavone, isoflavone, and xanthone derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Synthesis and pharmacological activities of xanthone derivatives as alpha-glucosidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Inhibition of protein kinase C by synthetic xanthone derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Conformationally restricted analogues of psorospermin: design, synthesis, and bioactivity of natural-product-related bisfuranoxanthones

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Xanthone derivatives as potential anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

Synthesis of new xanthone analogues and their biological activity test--cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.06.0002

21 January 2018

Identifiers

DOI

10.1211/JPP.61.06.0002

1 reference

20 August 2017

1 reference

PubMed ID

19505360